GEA has been selected by Hanmi Pharmaceutical, one of the largest drug manufacturers in Korea, to supply manufacturing equipment for a new plant that’s currently under construction in the city of Pyeongtaek-si in the Gyeonggi province of South Korea.
GEA is providing two production lines for insulin, including centrifugal separators, fermenters, homogenizers, flow components, and a significant number of aseptic valves. The multimillion euro order, received and booked as order intake in 2016, is scheduled for completion during 2017, and further reinforces the cooperative business relationship between the two companies.
The project represents a successful interdisciplinary collaboration within GEA itself, and with Yujin Hitec, GEA’s long-term distribution partner in the region.
The order from Hanmi includes equipment for two identical fermentation and media preparation lines, fully equipped with GEA VESTA® valves, for the production of a fragment of human immunoglobulin type G.
